M Schären, T Snedec, B Riefke, M Slopianka, M Keck, S Gruendemann, J Wichard, N Brunner, S Klein, K B Theinert, F Pietsch, A Leonhardt, S Theile, F Rachidi, A Kaiser, G Köller, E Bannert, J Spilke, A Starke
Dairy cows in modern production systems are at risk to develop metabolic disorders during the transition period. Reasons for individual differences in susceptibility, as well as the underlying pathomechanisms, are still only partially understood. The development of metaphylactic treatment protocols is needed. In this context, an on-farm prospective 3-fold blinded randomized study involving 80 German Holstein cows was performed throughout 1 yr. The trial involved a thorough recording of the production and clinical traits, clinical chemistry, and liver biopsies and blood and urine sampling at d 14 (mean: 12 d, range: 1-26 d) antepartum (AP), and d 7 (7, 4-13) and 28 (28, 23-34) postpartum (PP) for metabolomics analyses...
May 20, 2021: Journal of Dairy Science